Endpoints News 生物医药· Elizabeth Cairns·· 2026-10-01AI 评分36
EASD26:Regeneron 抗体助力停用 Wegovy 的患者恢复肌肉
#EASD26: Regeneron's antibody helps patients regain muscle after stopping GLP-1 therapy
AI 导读
在 EASD26 会议上,Regeneron 展示其 investigational drug(研究性药物)的效果。该药物帮助停用 Novo Nordisk 的 Wegovy 的肥胖患者恢复了与体重下降期间失去的肌肉量相似的肌肉质量。 (注:由于原文在关键数据处截断,仅保留了明确提及的主体、药物名称和核心结果描述,未添加原文未提供的具体数值或统计结果。)
正文
MILAN — Regeneron’s investigational drug helped obesity patients who stopped taking Novo’s Wegovy regain a similar amount of muscle mass to what they lost when they …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news